Literature DB >> 11274916

Anti-CD20 antibody therapy is highly effective in the treatment of follicular lymphoma.

H Marshall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11274916     DOI： 10.1016/s1471-4906(01)01909-3

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


× No keyword cloud information.
  3 in total

1.  CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma.

Authors:  Eric D Hsi; Roxanne Steinle; Balaji Balasa; Susann Szmania; Aparna Draksharapu; Benny P Shum; Mahrukh Huseni; David Powers; Amulya Nanisetti; Yin Zhang; Audie G Rice; Anne van Abbema; Melanie Wong; Gao Liu; Fenghuang Zhan; Myles Dillon; Shihao Chen; Susan Rhodes; Franklin Fuh; Naoya Tsurushita; Shankar Kumar; Vladimir Vexler; John D Shaughnessy; Bart Barlogie; Frits van Rhee; Mohamad Hussein; Daniel E H Afar; Marna B Williams
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

2.  Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property.

Authors:  Elham Khodaverdi; Zinat Heidari; Sayyed A Sajadi Tabassi; Mohsen Tafaghodi; Mona Alibolandi; Farnaz Sadat Mirzazadeh Tekie; Bahman Khameneh; Farzin Hadizadeh
Journal:  AAPS PharmSciTech       Date:  2014-09-16       Impact factor: 3.246

3.  pH-sensitive degradable nanoparticles for highly efficient intracellular delivery of exogenous protein.

Authors:  Dan Xu; Fei Wu; Yinghui Chen; Liangming Wei; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2013-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.